Compare Charles River Laboratories Intl. Inc (CRL) vs Meta Platforms Inc (META) Price & Performance

Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.

Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.

Meta Platforms (META) trades at $656.73, down 1.86% on the day, but maintains strong technical momentum with bullish moving averages and key support at $653. The company demonstrates robust fundamentals with 2025 revenue of $201B, net income of $60.5B, and consistent earnings beats. Recent AI developments including the Muse Spark launch and a $21B CoreWeave deal highlight growth initiatives. Analyst sentiment remains overwhelmingly positive with 79% buy ratings and a $815.44 consensus target.

Meta presents compelling growth potential driven by AI innovation and strong financial execution, though investors face risks from ongoing litigation and high capital expenditures. The stock trades at reasonable valuations (P/E 24.04) with significant upside to analyst targets, but requires monitoring of regulatory challenges and competitive pressures in the social media landscape.